It’s been clear for years that CRISPR would have significant utility outside of simple genome editing. | VedaBio debuted with a CRISPR platform to detect an array of molecules at room ...

Discover how CRISPR gene editing is creating personalized cancer therapies, enhancing immunotherapy, and offering new hope for hard-to-treat cancers.

Scientists study a molecular machine that moves jumping genes in DNA, paving the way for a new gene editing tool beyond ...

Gene editing promised a revolution, but biotech layoffs, stock slumps, and industry struggles reveal a stark reality: CRISPR is hard to do profitably.

Highly targeted CRISPR delivery system advances gene editing in living animals Antibody-targeted 'enveloped delivery vehicles' selectively edit T-cells to create CAR T-cells. Date: February 2 ...

A CRISPR system detects rare cancer mutations in blood with single-nucleotide precision, outperforming ddPCR through ...

However, CRISPR Therapeutics is not without its challenges. It faces intense competition from other gene-editing companies, both within and outside the CRISPR/Cas9 platform.

STAT series looks at movers and shakers in the life sciences. Here are 10 scientists developing new therapeutic applications of CRISPR ...

AMD, CRISPR Therapeutics, Paycom Software, DraftKings, Tesla: Why These 5 Stocks Are On Investors' Radars Today by Benzinga Neuro Benzinga Staff Writer Follow AMD Advanced Micro Devices Inc ...

CRISPR offers an alternative to both. But if, unlike them, it is to live up to its promise, it will need to attract a continuing flow of investment—which, in turn, means chalking up some real ...

A team of doctors at the Children's Hospital of Philadelphia and Penn Medicine treated a baby with a gene editing technology customized for his rare disease for the first time ever.

CRISPR Therapeutics has rallied on Casgevy progress, but overvaluation, early-stage pipeline, and lack of profits raise concerns. Find out why CRSP stock is a sell.